2m 2m 2m 2m 2m 2m 2m
Solventum (SOLV)
NYSE
$85.47+$0.03 (+0.04%)
Price as of Aug 03, 2026 4:01 AM EDT- $14.8BMarket Cap
- 19.11%1-Year Change
- Medical Instruments & SuppliesIndustry
Solventum (SOLV)
$85.47+$0.03 (+0.04%)
SOLV | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $85.44 | ||
Change | -$1.38 (-1.59%) | ||
Open | $86.12 | ||
High | $86.39 | ||
Low | $84.72 | ||
Previous Close | $86.82 | ||
Volume | 1,056,913 | ||
30-Day Average Volume | 1,064,734 | ||
1-Week Change | 9.52% | ||
1-Month Change | 10.75% | ||
1-Year Change | 19.11% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 173.2M | ||
Total Assets | $14.1B | ||
Market Cap | $14.8B | ||
Enterprise Value | $19.3B | ||
Period: QTR TTM FY | |||
Revenue | $1.5B | ||
Net Income | $13.0M | ||
Free Cash Flow | -$273.0M | ||
EBIT | $78.0M | ||
EBITDA | $213.0M | ||
Net Working Capital | $237.0M | ||
EPS | $0.07 | ||
Enterprise Value/EBITDA | 91 | ||
Enterprise Value/Revenue | 13 | ||
P/B | 3 | ||
P/E | 1,221 | ||
PEG | -15 | ||
Price/Free Cash Flow | -54 | ||
Price/Operating Cash Flow | -78 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue